Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/199929
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/199929
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

SHAKER DAKHIL

Listed Specialty: Hematology & Oncology
818 N EMPORIA ST, SUITE 403, WICHITA, KS, 67214-3729

2018 Payments: At a Glance

396

payments

$125,963

payment total

38

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 13 $40,752
Promotional Speaking/Other
 12 $31,670
Charitable Contribution
 1 $30,000
Travel and Lodging
 47 $16,059
Food and Beverage
 312 $7,404
Education
 11 $78

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
Payments with no listed product

N/A

 $46,859
LENVIMA

drug

 $19,569
ABRAXANE

drug

 $17,662
REVLIMID

drug

 $12,192
HALAVEN

drug

 $6,756
TAGRISSO

drug

 $5,877
XALKORI

drug

 $3,822
IMBRUVICA

drug

 $3,558
NERLYNX

drug

 $2,243
VENCLEXTA

drug

 $1,168
STIVARGA

drug

 $935
ZOLADEX

drug

 $911
VARUBI

drug

 $817
MEKINIST

drug

 $235
TAFINLAR

drug

 $235
KEYTRUDA

drug

 $235
ADCETRIS

drug

 $199
GILOTRIF

drug

 $178
JAKAFI

drug

 $175
RUBRACA

drug

 $166
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/199929

Payment Details

When How Much Related To What For From Third Party Payee
Aug 13, 2018 $30,000 No Listed Product Charitable Contribution MCKESSON SPECIALTY CARE DISTRIBUTION, LLC Wichita Cancer Foundation
Dec 20, 2018 $6,475 REVLIMID Consulting CELGENE CORPORATION
Jul 13, 2018 $5,130 HALAVEN Consulting EISAI INC.
Nov 13, 2018 $5,000 TAGRISSO Consulting ASTRAZENECA PHARMACEUTICALS LP
Dec 11, 2018 $4,625 LENVIMA Promotional Speaking/Other EISAI INC.
Oct 25, 2018 $4,625 LENVIMA Promotional Speaking/Other EISAI INC.
Jan 3, 2018 $4,122 No Listed Product Consulting OTSUKA AMERICA PHARMACEUTICAL, INC.
Jul 25, 2018 $3,850 ABRAXANE Promotional Speaking/Other CELGENE CORPORATION
Dec 11, 2018 $3,800 XALKORI Consulting PFIZER INC. SHAKER R DAKHIL
Feb 12, 2018 $3,600 No Listed Product Consulting GILEAD SCIENCES INC
Jun 27, 2018 $3,525 LENVIMA Promotional Speaking/Other EISAI INC.
Nov 1, 2018 $3,500 No Listed Product Consulting ABBVIE, INC.
Jan 18, 2018 $3,025 LENVIMA Promotional Speaking/Other EISAI INC.
Nov 13, 2018 $3,000 No Listed Product Consulting ABBVIE, INC.
Apr 23, 2018 $2,625 ABRAXANE Promotional Speaking/Other CELGENE CORPORATION
Sep 6, 2018 $2,625 REVLIMID Promotional Speaking/Other CELGENE CORPORATION
Jul 25, 2018 $2,625 ABRAXANE Promotional Speaking/Other CELGENE CORPORATION
May 15, 2018 $2,625 ABRAXANE Promotional Speaking/Other CELGENE CORPORATION
Jun 28, 2018 $2,000 IMBRUVICA Consulting PHARMACYCLICS LLC, AN ABBVIE COMPANY
Sep 6, 2018 $1,403 REVLIMID Travel and Lodging CELGENE CORPORATION

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/199929

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.